These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2971387)

  • 1. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
    Saksela O; Rifkin DB
    J Cell Biol; 1990 Mar; 110(3):767-75. PubMed ID: 2137829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulphate proteoglycans.
    Gallagher JT; Turnbull JE; Lyon M
    Biochem Soc Trans; 1990 Apr; 18(2):207-9. PubMed ID: 2143154
    [No Abstract]   [Full Text] [Related]  

  • 6. Murine T lymphocytes and T-lymphoma cells produce chondroitin sulphate and heparan sulphate proteoglycans and free heparan sulphate glycosaminoglycan.
    Wilson AP; Rider CC
    Immunology; 1991 Jan; 72(1):27-33. PubMed ID: 1900056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectron microscopy of endothelial cells in rat incisor suggests that most basement membrane components are produced by young cells, whereas heparan sulfate proteoglycan is produced by both young and old cells.
    Murray IC; Leblond CP
    J Histochem Cytochem; 1988 Jul; 36(7):763-73. PubMed ID: 2968396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate-binding peptide promotes the deposition of proteoglycans in the extracellular matrix.
    Colburn P; Kobayashi E; Buonassisi V
    J Cell Biochem; 1997 Jun; 65(4):574-90. PubMed ID: 9178106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heparan sulphate proteoglycan and retinal microinfarcts in diabetes mellitus.
    Roy MS; Rick ME
    Diabetologia; 1989 Oct; 32(10):766. PubMed ID: 2531690
    [No Abstract]   [Full Text] [Related]  

  • 11. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation.
    Cisar LA; Hoogewerf AJ; Cupp M; Rapport CA; Bensadoun A
    J Biol Chem; 1989 Jan; 264(3):1767-74. PubMed ID: 2521485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of heparan sulfate proteoglycan in the basement membrane of continuous capillaries.
    Charonis AS; Tsilibary PC; Kramer RH; Wissig SL
    Microvasc Res; 1983 Jul; 26(1):108-15. PubMed ID: 6225004
    [No Abstract]   [Full Text] [Related]  

  • 13. High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells.
    Olgemöller B; Schleicher ED; Schwaabe S; Guretzki HJ; Gerbitz KD
    FEBS Lett; 1990 May; 264(1):37-9. PubMed ID: 2140100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of heparan sulfate moieties in cultured endothelial cells exposed to endotoxin.
    Colburn P; Dietrich CP; Buonassisi V
    Arch Biochem Biophys; 1996 Jan; 325(1):129-38. PubMed ID: 8554337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
    Dawes J; Pepper DS
    Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans.
    Brandan E; Maldonado M; Garrido J; Inestrosa NC
    J Cell Biol; 1985 Sep; 101(3):985-92. PubMed ID: 3161900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
    Morrison P; Lowe-Krentz LJ
    Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a small hydrophobic domain in the core protein of the heparan sulfate proteoglycan from human colon carcinoma cells.
    Iozzo RV; Ketterer CL; Slaymaker DJ
    FEBS Lett; 1986 Oct; 206(2):304-8. PubMed ID: 2944764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens.
    Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I
    Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.